As AI reshapes medical coding, patients and employers may end up paying more without receiving the right level of care.
Absent any statutory consequences for not completing the OPPS Drug Acquisition Cost Survey (ODACS), it is wrong for CMS to tell hospitals and health systems that they “are to” complete it.
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
Hospital groups push CMS to revise drug cost survey language that misleadingly implies mandatory hospital responses under OPPS rules.